The Rewire Study (Mindfulness Mobile App to Reduce Adolescent Substance Use)

Mindfulness Mobile App to Reduce Adolescent Substance Use

The current proposal is aimed at developing a substance use cessation app (Rewire) for high risk adolescents who are involved in the juvenile justice system. The Rewire app will be based on the primary substance use cessation components tested in our previous work with juvenile justice-involved adolescents and on intervention components shown to be central to smoking cessation.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The Rewire Study will recruit 60 youth (30 boys and 30 girls) who have had contact with the Department of Youth Services in the last year. Consent will be obtained from parents or guardians for the youths' participation. The participating teens will come to Oregon Research Institute for a baseline assessment. During this visit, the teens will complete an assent form and spend spent 20-30 minutes completing an online survey with an assessor; topics covered in the survey include emotion regulation and drug and alcohol use. Teens will have the app loaded onto their phones and be provided with instructions for its use during this visit. Participants are asked to use the app over the next 2 weeks, completing 4 modules and spending 5-10 minutes each day answering questions about recent emotions and substance use. Teens will be contacted via email for follow up assessments at 2 weeks and 2 months post-baseline. These emails will contain links to the follow-up survey which also asks about emotion regulation and drug and alcohol use; surveys should take 20-30 minutes to complete.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Eugene, Oregon, United States, 97403
        • ORBIS/Oregon Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ages 13 to 17
  • involved with Juvenile Justice system
  • documented substance use
  • English-speaking
  • living in the community

Exclusion Criteria:

  • non English-speaking
  • living in treatment or detention facility

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: App Evaluation
All 60 teens in The Rewire Study will complete the first 4 modules of the Rewire app. Prior to using the app, they will complete a baseline assessment. Follow up surveys will be completed at 2 weeks and 8 weeks post-baseline.
A prototype Rewire app will be designed and created; the first four modules will be evaluated by 60 high-risk adolescents. The teens are asked to complete each module and spend a few minutes each day for two weeks using the practice exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Adolescent Attitudes toward Substance Use
Time Frame: Baseline, 2 weeks, 8 weeks
Adolescent Attitudes toward Substance Use measures beliefs about social norms and consequences. Higher scores represent more prosocial attitudes.
Baseline, 2 weeks, 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Adolescent Mindfulness Practices
Time Frame: Baseline, 2 weeks, 8 weeks
Mindfulness is measured by the Five Facet Mindfulness Questionnaire. The five facets are observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Maximum score is 40 for the first 4 scales and 35 for the last. Higher scores indicate a greater tendency toward each element of mindfulness.
Baseline, 2 weeks, 8 weeks
Changes in Emotion Regulation
Time Frame: Baseline, 2 weeks, 8 weeks
Emotion Regulation is measured by the Difficulties in Emotion Regulation Scale. Higher scores indicate greater problems with emotion regulation. Total score will range from 77 to 121.
Baseline, 2 weeks, 8 weeks
Evaluate first 4 modules of prototype app
Time Frame: Intervention period (time of app use) is from Baseline to 2 week follow up
Participant satisfaction ratings are collected through interview questions
Intervention period (time of app use) is from Baseline to 2 week follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dana K Smith, Ph.D., Oregon Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2018

Primary Completion (Actual)

August 30, 2018

Study Completion (Actual)

October 31, 2018

Study Registration Dates

First Submitted

April 17, 2018

First Submitted That Met QC Criteria

May 10, 2018

First Posted (Actual)

May 23, 2018

Study Record Updates

Last Update Posted (Actual)

March 13, 2019

Last Update Submitted That Met QC Criteria

March 12, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • DA043288-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent Substance Use

Clinical Trials on Rewire App

3
Subscribe